Table 1.
Medical and demographic characteristics of participants at the moment of diagnosis, by treatment type
| AS | RP | RT | Reference group | P value* | |
|---|---|---|---|---|---|
| Number of participants | 120 | 69 | 219 | 204 | |
| Age at treatment (mean, SD) | 65.3 (6.4) | 70.0 (2.6) | 65.9 (6.2) | <0.001 | |
| Age at time of questionnaire (mean, SD) | 71.9 (6.4) | 76.0 (2.6) | 74.5 (6.4) | 74.5 (1.6) | <0.001 |
| Follow-up time in years (mean, SD) | 6.6 (1.6) | 6.0 (1.5) | 8.6 (3.4) | <0.001 | |
| PSA at diagnosis (mean, SD) | 5.9 (3.1) | 7.3 (6.1) | 7.5 (3.1) | <0.001 | |
| Clinical stage at diagnosis (n, %) | |||||
| T1c | 98 (81.7%) | 44 (66.7%) | 147 (68.1%) | 0.012 | |
| T2a | 22 (18.3%) | 22 (33.3%) | 72 (33.3%) | ||
| Missing | 0 | 3 | 3 | ||
| Gleason score at diagnosis (n, %) | |||||
| 4 | 2 (1.7%) | 0 | 0 | <0.001 | |
| 5 | 3 (2.5%) | 2 (2.9%) | 4 (2.1%) | ||
| 6 | 115 (95.8%) | 46 (66.7%) | 170 (89.0%) | ||
| 7 | 0 | 21 (30.4%) | 17 (8.9%) | ||
| Missing | 0 | 0 | 28 | ||
| Education (n, %) | |||||
| Low | 30 (25.4%) | 21 (31.3%) | 57 (26.6%) | 73 (35.8%) | 0.002 |
| Intermediate | 41 (34.7%) | 33 (49.3%) | 89 (41.6%) | 82 (40.2%) | |
| High | 44 (37.3%) | 13 (19.4%) | 62 (29.0%) | 43 (21.1%) | |
| Other | 3 (2.5%) | 0 | 6 (2.8%) | 6 (2.9%) | |
| Missing | 2 | 2 | 5 | 0 | |
| Working status (n, %) | |||||
| Employed | 15 (12.5%) | 2 (3.0%) | 16 (7.4%) | 4 (2.0%) | 0.001 |
| Retired | 103 (85.8%) | 63 (95.5%) | 193 (89.4%) | 199 (97.5%) | |
| Other | 2 (1.7%) | 1 (1.5%) | 7 (3.2%) | 1 (0.5%) | |
| Missing | 0 | 3 | 3 | 0 | |
| Civil status (n, %) | |||||
| Married/living together | 105 (87.5%) | 53 (79.1%) | 181 (83.0%) | 177 (86.8%) | 0.304 |
| Other | 15 (12.5%) | 14 (20.9%) | 37 (17.0%) | 27 (13.2%) | |
| Missing | 0 | 2 | 1 | 0 | |
*Significance tested with ANOVA for all four groups where applicable and three groups for the clinical characteristics